We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Microwave Radiation Promising for Breast Cancer

By HospiMedica staff writers
Posted on 14 Oct 2002
In a phase II trial, microwave radiation focused externally on the breast resulted in significant tumor kill in a majority of patients. More...
The results were reported in the May 2002 issue of the Annals of Surgical Oncology.

The technology was invented by Dr. Alan J. Fenn, a senior staff member at the Lincoln Laboratory of the Massachusetts Institute of Technology (MIT, Cambridge, MA, USA). Dr. Fenn realized that the same focused microwave technology used for missile detection could perhaps be used to treat breast cancer cells. A new randomized clinical trial enrolling 220 women has already begun.

The microwave thermotherapy technology was licensed to Celsion Corp. (Columbia, MD, USA) which developed the clinical system and is now funding the clinical studies. Celsion calls the system Adaptive Phased Array Thermotherapy. Treatment takes only about 60 minutes. The focused microwaves generate heat, which shrinks large tumors and kills small ones. The goal of the therapy is to kill tumor cells and reduce additional surgery.




Related Links:
Celsion

Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Enteral Feeding Pump
SENTINELplus
Medical Monitor
SILENIO D
Silver Member
ECG Management System
NEMS Web
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.